Stereocomplexes for the delivery of anti-cancer agents
US-2024350644-A1 · Oct 24, 2024 · US
US10138327B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10138327-B2 |
| Application number | US-201414585413-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 30, 2014 |
| Priority date | Nov 13, 2009 |
| Publication date | Nov 27, 2018 |
| Grant date | Nov 27, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The disclosure relates to oxygen scavenging polymer compositions, methods of making the compositions, articles prepared from the compositions, and methods of making the articles. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
Opening claim text (preview).
What is claimed is: 1. A wall of a package comprising at least one layer, said layer comprising a composition, said composition comprising: (a) a thermoplastic polymer comprising an allylic or benzylic amide compound covalently bonded as a repeating unit in the polymer chain, covalently bonded thereto as a side-chain pendant group, or covalently bonded thereto as an end group of the polymer, double bond; wherein each n is independently 1-5; wherein m is an integer from 0 to 5-n; wherein each X is independently selected from the group consisting of O, S, and NH; wherein each Y, each A, and each B are independently selected from the group consisting of N, CR 1 , and CR 2 ; wherein D, E, and F are independently selected from the group consisting of CH, N, O, and S; wherein each R 1 and each R 2 is independently selected from the group consisting of carboxylic acid, amine, nitro, cyano, hydroxyl, H, alkyl, aryl, electron withdrawing groups, electron releasing groups, and a transition metal; and wherein L is a divalent linking group selected from C2-C12 aliphatic or cyclic ether, C2-C12 aliphatic or cyclic amide, C6 to C12 aromatic amide, C2-C12 aliphatic or cyclic amine, C6-C12 aromatic amine, C2-C12 aliphatic or cyclic ester and C6 to C12 aromatic ester; wherein the symbol when used in conjunction with a bond line represents a single or a double bond; wherein each n is independently 0-5; wherein m is an integer from 0 to 5-n; wherein each X is independently selected from the group consisting of O, S, and NH; wherein each Y, each A, and each B are independently selected from the group consisting of N, CR 1 , and CR 2 ; wherein D, E, and F are independently selected from the group consisting of CH, N, O, and S; wherein each R 1 and each R 2 is independently selected from the group consisting of carboxylic acid, amine, nitro, cyano, hydroxyl, H, alkyl, aryl, electron withdrawing groups, electron releasing groups, and a transition metal; and wherein L is a divalent linking group selected from C2-C12 aliphatic or cyclic ether, C2-C12 aliphatic or cyclic amide, C6 to C12 aromatic amide, C2-C12 aliphatic or cyclic amine, C6-C12 aromatic amine, C2-C12 aliphatic or cyclic ester and C6 to C12 aromatic ester; or wherein each X is selected from the group consisting of O, S, and NH; wherein each Y, each A, and each B are independently selected from the group consisting of N and CR 1 ; wherein D, E, and F are independently selected from the group consisting of CH, N, O, and S; wherein the symbol when used in conjunction with a bond line represents a single or a double bond; and wherein each R 1 is independently selected from the group consisting of H, alkyl, aryl, electron withdrawing groups, and electron releasing groups; and (b) a transition metal in a positive oxidation state, the metal present in an amount of from about 10 ppm to about 400 ppm. 2. The wall of claim 1 , wherein the amide compound is present in the composition in an amount of from 0.1 to about 10 weight percent. 3. The wall of claim 1 , wherein the amide compound is present in the composition in an amount of from 1 to about 3 weight percent. 4. The wall of claim 1 , wherein the amide compound is:
Dicarboxylic acids and dihydroxy compounds · CPC title
Unsaturated polyimide precursors · CPC title
Polymers modified by chemical after-treatment · CPC title
Polymer or resin containing [i.e., natural or synthetic] · CPC title
Optical brightening agents, organic pigments · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.